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Pluripotent stem cells (PSCs) represent a unique kind of stem cell, as they are able to indefinitely self-renew and hold the potential
to differentiate into any derivative of the three germ layers. As such, human Embryonic Stem Cells (hESCs) and human induced
Pluripotent Stem Cells (hiPSCs) provide a unique opportunity for studying the earliest steps of human embryogenesis and, at
the same time, are of great therapeutic interest. The molecular mechanisms underlying pluripotency represent a major field of
research. Recent evidence suggests that a complex network of transcription factors, chromatin regulators, and noncoding RNAs
exist in pluripotent cells to regulate the balance between self-renewal andmultilineage differentiation. Regulatory noncoding RNAs
come in two flavors: short and long. The first class includes microRNAs (miRNAs), which are involved in the posttranscriptional
regulation of cell cycle and differentiation in PSCs. Instead, long noncoding RNAs (lncRNAs) represent a heterogeneous group of
long transcripts that regulate gene expression at transcriptional and posttranscriptional levels. In this review, we focus on the role
played by lncRNAs in the maintenance of pluripotency, emphasizing the interplay between lncRNAs and other pivotal regulators
in PSCs.
1. Introduction
The term long noncoding RNAs (lncRNAs) refers to a hetero-
geneous class of RNA polymerase II (Pol II) transcripts
greater than 200 nucleotides in length with no evident
protein-coding capacity [1, 2].They are generally spliced from
multiexonic precursors, capped, polyadenylated, and local-
ized to the nucleus, cytoplasm, or both [2, 3]. Based on the
anatomical properties of their transcription loci and the rela-
tionship with the adjacent genes, lncRNAs can be classified in
intronic, intergenic, or overlapping (in sense or antisense
orientation) transcripts. Even though lncRNAs are less con-
served than mRNA and small noncoding RNAs [4, 5], lack of
conservation does not imply a lack of function [6]. Indeed,
both the transcript length and the versatility of RNA to
base-pair let these molecules fold into complex secondary
structures [7, 8], which are interspersed with longer and less
conserved stretches of nucleotide sequences. As highlighted
by pioneering studies [1, 6], these structures allow lncRNAs
to simultaneously interact with multiple complexes, thereby
coordinating their activities.
Even though only a part of lncRNA transcripts have been
mechanistically characterized, several studies have shown the
participation of lncRNAs in different processes related to
normal physiology and/or disease [4, 6]. As they are Pol
II transcripts, lncRNA expression can be tightly regulated.
Indeed lncRNA transcripts are globally more tissue specific
than protein-coding genes suggesting potential roles in spec-
ifying cell identity [9, 10].
The intracellular localization of lncRNAs is predictive of
their mode of action [6, 10]. Usually, nuclear lncRNAs can
guide chromatin modification complexes to specific genomic
loci and/or serve as molecular scaffolds that tether together
distinct functionally related complexes [11, 12]. Due to their
intrinsic ability to base-pair with other nucleic acids, both cis-
acting (on neighboring genes) and trans-acting (on distant
loci) lncRNAs can exert either repressive or promoting
activities on target genes by coordinating protein and RNA
interactions [12–14]. Based on known examples [12], nuclear
lncRNAs can exert their regulatory function as decoys by
simply titrating transcription factors and other proteins
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away from chromatin [15–17]. As a paradigm, depletion of
the lncRNA PANDA substantially increased target genes
occupancy by NF-YA, a nuclear transcription factor that
triggers apoptosis upon DNA damage [17]. lncRNA binding
on DNA can initiate the formation of heterochromatin by
recruitment of DNA or histone methyltransferases (such
as the histone H3 lysine 27, H3K27, and methyltransferase
complex PRC2), resulting in repression of gene expression.
Conversely, transcriptional activation can be induced by
recruitment of different chromatin modifiers, such as the H3
lysine 4, H3K4, and methyltransferase MLL1, or by changing
the 3D chromatin conformation [12, 13]. Among the cis-
acting species, the enhancer-associated ncRNAs (eRNAs) are
functional transcripts participating in many programs of
gene activation. In particular, they play fundamental roles
in targeting chromatin-remodeling complexes to specific
promoters and to assist the formation of chromatin loops
[18]. Using an integrated epigenomic screening, Ounzain
and colleagues recently established a catalogue of enhancer-
associated noncoding RNAs dynamically expressed in ESCs
during cardiac differentiation [19]. The expression of these
transcripts correlated with the expression of target genes
in their genomic proximity. Interestingly, the expression of
the eRNAs was inhibited when the target mRNAs reached
maximal levels. Overall, these data gave an important con-
tribution to the functional impact of cardiac eRNAs on heart
development and cardiac remodeling after injury.
Some other lncRNAs are localized in the cytoplasm,
where they can regulate gene expression through base-
pairing complementary regions on target RNAs. In human,
several cytoplasmic lncRNAs transactivate Staufen1-
mediated mRNA decay by duplexing with 3󸀠UTRs via
Alu elements [20]. Another example is represented by the
𝛽-site APP-cleaving enzyme 1 BACE1-AS antisense RNA,
which binds to BACE1 mRNA inducing its stabilization. By
regulating BACE1 expression, the noncoding RNA plays a
role in controlling the boundaries between physiology and
pathology driving Alzheimer’s disease pathology [21]. Base-
pairing is also the principle that applies to the competing
endogenous RNA (ceRNA) activity of lncRNAs [22]. In this
case, lncRNAs can indirectly enhance protein translation
by sequestering, or “sponging,” miRNAs that otherwise
would inhibit their target mRNAs. This mechanism has been
shown to be involved in differentiation and cancer [22, 23].
Finally, a peculiar class of sponging lncRNAs is represented
by circular RNAs (circRNAs) [24, 25], whose unusual
circular structure confers increased stability. Altogether,
these different properties engender lncRNAs to operate
through distinct modes of action and to exert a wide range
of functions across diverse biological processes.
Embryonic Stem Cells (ESCs) are the in vitro counterpart
of the pluripotent epiblast of the blastocyst and constitute
a useful system to study the molecular mechanisms at the
basis of pluripotency. A group of transcription factors (TFs),
comprising OCT4, NANOG, and SOX2, has been proposed
as the core regulatory circuitry in ESCs [26]. These are
pluripotency factors that ensure the proper expression of
genes involved in the maintenance of the undifferentiated
state. At the same time, they repress many genes that play
a role during subsequent development. Such developmental
genes, however, are often kept in a silent but “poised”
state by the establishment of bivalent chromatin domains,
where histone repressive marks coexist with marks related
to active transcription [27]. It is now becoming clear that
the core pluripotency TFs operate in concert with miRNAs
and lncRNAs [28–30]. One example of a miRNA family
that plays a role in the crossroad between pluripotency
and differentiation is the miR-302 family [31]. Among other
activities, miR-302 regulates the balance between agonists
and antagonists of the TGF𝛽/BMP signalling, which is a
crucial pathway for the choice between maintenance of
pluripotency and differentiation [32]. In ESCs, the activity of
miR-302 is counteracted by let-7, an opposing miRNA family
that plays a prodifferentiative role [33]. Other miRNAs also
facilitate differentiation by targeting pluripotency factors or
chromatin modifiers [28]. In this review, we focus on recent
evidence suggesting that lncRNAs also play an important role
in the maintenance of pluripotency.
ESCs have represented for a long time the only system to
model human early development. More recently, the Nobel
Prize-awarded derivation of induced Pluripotent Stem Cells
(iPSCs) provided an alternative source of pluripotent cells
[34]. iPSCs can be derived from human somatic adult cells
through a reprogramming process consisting in the ectopic
expression of defined factors. As their derivation requires
a simple skin biopsy (or blood sampling), human iPSCs
overcome ethical and legislative issues that limit the research
based on humanESCs (hESCs). Importantly, iPSCs generated
from human patients with genetic disorders represent a
promising tool for both regenerative medicine and in vitro
disease modeling.
2. The lncRNA Signature in
Embryonic Stem Cells
As for protein-coding genes and miRNAs [31], Pluripotent
Stem Cells express a characteristic set of lncRNAs. The
lncRNA signature of mouse ESCs (mESCs) has been defined
by microarray analysis [35] and genome-wide mapping of
chromatin marks of actively transcribed genes, such as
trimethylation of lysine 4 of histone H3 (H3K4me3) in the
promoter coupled with trimethylation of lysine 36 of histone
H3 in the transcribed region (K4-K36 domain) [36]. Work
by Dinger et al. [35] identified several lncRNAs that are
differentially expressed in proliferating mESCs and upon
induction of hematopoietic differentiation. Analysis of K4-
K36 domains located outside the known protein-coding loci
allowed Guttman et al. [36] to identify over a thousand
novel lncRNAs in mESCs and somatic cells. The catalogue of
mESC lncRNAswas then expanded by including a substantial
fraction of species transcribed from genes not marked by a
K4-K36 domain, identified by a computational method that
allowed the reconstruction of the whole transcriptome from
RNA-Seq data (Scripture) [37]. A significant subset of these
lncRNAs may be regulated at the transcriptional level by the
ESC core TFs [29, 38].
As in the case of mouse ESCs, K4-K36 domains analysis
allowed the initial identification of a characteristic set of
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lncRNAs genes expressed in human ESCs [39]. This list was
then further extended by integrating data from RNA-Seq
analysis [4]. A more detailed characterization has shown that
some human lncRNAs could be under the direct control of
the core pluripotency TFs [40, 41].
3. lncRNAs Play a Role in the Maintenance of
Pluripotency in ESCs
Increasing evidence points to a crucial role for lncRNAs in the
maintenance of ESC self-renewal (pluripotency), thus pre-
venting their differentiation. In a large-scale functional study,
the individual knockdown ofmore than 90%of lncRNAs (out
of 147 tested) caused a significant perturbation of the tran-
scriptome, often resulting in the loss of mESC pluripotency
[29]. Interestingly, lncRNAs involved in the maintenance of
ESC self-renewal are often transcriptionally regulated by core
pluripotency TFs and act in regulatory networks. Exam-
ples of this mechanism include AKO28326/GOMAFU/MIAT
(OCT4-activated) and AK141205 (NANOG-repressed) lncR-
NAs that when altered lead to robust changes in OCT4 and
NANOG levels and affected pluripotency of mESCs [38].
The lncRNA TUNA/MEGAMIND is required for mESCs
proliferation and maintenance of self-renewal [5]. TUNA
binds a complex comprising several RNA-binding proteins
and activates transcription of NANOG and SOX2 upon
binding on their promoters [42]. The interplay between
core TFs and lncRNAs has been reported also in hESCs
for lncRNA ES1, lncRNA ES2, and lncRNA ES3 [40]. Taken
together, these examples indicate that lncRNAs are involved
in the maintenance of the undifferentiated state and the
repression of genetic programs that direct lineage commit-
ment during differentiation.
The challenge now is to dissect the molecular mech-
anisms underlying the functions of these ESC lncRNAs.
Mechanistically, nuclear lncRNAsmay exert their function by
binding and regulating the activity and/or target specificity
of chromatin-modifying factors. It has been shown that
ESC lncRNAs interact with all classes of histone modifiers
(writers, readers, and erasers), as well as other chromatin-
associated proteins [29]. This is in line with a possible role
of these long transcripts as molecular scaffolds that bridge
together different chromatin modification complexes [11].
Recent examples support the hypothesis that lncRNAs may
be pivotal regulators of the activity of crucial chromatin
modifiers, which play an essential role in the epigenetic reg-
ulation of ESCs pluripotency and differentiation. Genome-
wide analysis identified a multitude of potential lncRNA
interactors of PRC2 in mESCs and a somewhat promiscuous
RNA-binding activity of this complex has been suggested
[43, 44]. Recent work proposed that lncRNA binding might
be important to modulate the interaction of PRC2 with its
cofactors, thus modulating its activity and/or specificity. One
of such cofactors is JARID2, belonging to the JUMONJI
family of lysine demethylases (KDMs). JARID2 is peculiar
as its KDM catalytic domain is inactive and it is particularly
enriched in ESCs where it regulates PRC2 activity and
genome occupancy [45, 46]. It has been recently shown that
JARID2 contains RNA-binding region and directly interacts
with about 100 previously annotated lncRNAs inmESCs [47].
Particularly interesting, among these interactors are MEG3
(also known as GTL2), RIAN, and MIRG, lncRNAs that are
encoded within an imprinted locus on chromosome 12qF1,
referred to as the Dlk1-Dio3 gene cluster. Proper expression
of these lncRNAs is required for embryonic development [48,
49] and to achieve full pluripotency during reprogramming,
as iPSCs carrying aberrantly silenced Dlk1-Dio3 cluster genes
are unable to fulfill stringent pluripotency tests, such as
contribution to chimaeric mice development and comple-
mentation of a tetraploid blastocyst [50]. Functionally, by
binding JARID2, MEG3 and other Dlk1-Dio3 gene cluster
lncRNAs may modulate the activity of PRC2 in Pluripotent
Stem Cells. Genome-wide analysis indeed showed that Meg3
stimulates PRC2 occupancy in trans at genomic loci encoding
for factors involved in differentiation and development [44].
These genes are derepressed in human iPSC lines expressing
low levels of MEG3, suggesting evolutionary conservation
of the MEG3-JARID2 axis. Mechanistically, MEG3 and
other lncRNAs work as scaffolds to increase the interaction
between JARID2 and the PRC2 core component EZH2 and,
therefore, PRC2 assembly on chromatin at JARID2 target
sites.Moreover, it has been suggested that these lncRNAsmay
also guide the initial recruitment of PRC2/JARID2 at specific
target sites in pluripotent cells via RNA-DNA base-pairing
[47] (Figure 1).
Trithorax group (TrxG) factors, including mammalian
MLL complexes, positively regulate transcription via the
H3K4me3. This activity is required to maintain pluripotency
in ESCs. In particular, the WDR5 member of the MLL com-
plex directly interacts with the core transcriptional regulatory
circuitry and its depletion causes loss of self-renewal [51]. By
taking advantage of an RNA-binding deficient mutant, Yang
and coworkers recently demonstrated that the interaction
with RNA is essential for WDR5 activity [52]. The half-
life of the WDR5 mutant protein in the nucleus is reduced
compared to wild-type, indicating that RNA binding posi-
tively regulates protein stability. Over 1000 RNAs might bind
WDR5 in ESCs, including 23 previously annotated lncRNAs.
Among these interactors, six were previously identified as
lncRNAs required to maintain pluripotency in mESCs [29],
providing amechanistic explanation of their function.WDR5
also binds the promoters of two of these interacting lncRNAs,
lincRNA-1592 and lincRNA-1552, suggesting a cis regulatory
mechanism [49]. lincRNA-1552 expression may be under the
direct control of many pluripotency transcription factors,
including OCT4, NANOG, and KLF4 that bind its promoter,
and its knockdown leads to misexpression of OCT4 and
NANOG, among other mRNAs [29]. This evidence, together
with the impairment of self-renewal in cells expressing the
RNA-binding deficient WDR5 mutant [52], suggests that
lncRNAs interacting with the Trithorax complex play a cru-
cial role in the maintenance of ESC pluripotency (Figure 1).
The interplay between lncRNAs and Trithorax complexes
may also direct specification towards specific cell fates upon
ESCs differentiation. The homeotic genes Hoxa6 and Hoxa7
are involved in the specification of mesoderm derived tissues
and organs [53, 54]. Bertani and colleagues demonstrated that
the lncRNA MISTRAL (MIRA) mediates the transcriptional
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Figure 1: Examples of nuclear lncRNAs interacting with chromatin regulators in ESCs. (a) The lncRNA MEG3 promotes the interaction
between the EZH2 subunit of PRC2 and JARID2, thus guiding PRC2 recruitment and H3K27me3 deposition at JARID2 target sites [47]. It
has also been proposed that lncRNAs specify the target site recognition of PRC2/JARID2 via RNA-DNA base-pairing (not shown) [47]. (b)
lincRNA-1552 transcription is promoted by core pluripotency factors and is required for ESC self-renewal [29]. This and other transcripts
positively regulate TrxG activity by binding and stabilizing the WDR5 cofactor [52].
activation of Hoxa6 and Hoxa7 genes by recruiting MLL
to chromatin [55]. MIRA-mediated activation of Hoxa6
and Hoxa7 culminates in the expression of genes involved
in early germ layer specification in differentiating mESCs.
Another interesting example of lncRNA involved in mESC
differentiation is pRNA, which is localized in the nucleo-
lus [56]. In Pluripotent Stem Cells, chromatin is globally
in a transcriptionally permissive open state and becomes
increasingly condensed and transcriptionally repressed upon
differentiation (reviewed in [57]). Chromatin condensation
occurs also at ribosomal genes and is promoted by pRNA,
which guides the nucleolar repressor factor TIP5/BAZ2A to
ribosomal DNA (rDNA) [56]. Interestingly, pRNA overex-
pression caused an increase of heterochromatin also outside
rDNA, initiating the global epigenetic remodeling normally
observed during differentiation.
In addition to nuclear ESC lncRNAs, on the other side
of the coin, fewer examples exist for cytoplasmic lncRNAs
that regulate pluripotency. During the initial steps of the
reprograming process, cells initiating their conversion to
pluripotency must elude inhibitory hurdles, such as cell cycle
arrest, senescence, and apoptosis, raised by p53 activation
by the overexpression of the reprogramming factors [58].
Thus, any change in p53 activity is predicted to affect the
efficiency of reprogramming by limiting the number of cells
entering the process. In this context, the cytoplasmic linc-
RoR (Regulator of Reprogramming) was initially identified as
lncRNA able to promote the reprogramming process [41] by
acting as a negative regulator of p53 [59]. Subsequently,Wang
and colleagues showed that endogenous linc-RoR also plays
a key role in the maintenance of hESC self-renewal by acting
as a ceRNA [60]. Previous work had shown that a single
miRNA,miR-145, inhibits translation of core TFs during ESC
differentiation [61]. According to the model by Wang et al.,
in human ESCs linc-RoR would trap miR-145, derepressing
the translation of the core pluripotency transcription factors
OCT4, SOX2, and NANOG and ensuring proper levels of
expression in undifferentiated hESC. Upon differentiation,
the disappearance of linc-RoR releases miR-145, allowing it
to repress the translation of core pluripotency factors [41].
Thus, this work strongly supports the idea that linc-RoR
acts as a miRNA sponge. Since OCT4, at the transcriptional
level, represses miR-145 and activates linc-RoR, these studies
unraveled an interesting network comprising TFs, long and
short regulatory RNAs which act at the crossroad between
self-renewal and differentiation (Figure 2).
More recently, Bao and colleagues [62] showed that
lincRNA-p21, a nuclear noncoding transcript previously
characterized as a global repressor of the p53-dependent
transcriptional cascade [63], represents another example of
lncRNA regulating pluripotency. Interestingly, in the context
of somatic cell reprogramming, lincRNA-p21 inhibits
this process without inducing apoptosis or impairing cell
proliferation. It was identified in a functional screening
performed in mouse to examine events accompanying the
pre-iPSCs to iPSCs conversion. This is a late step, required
to achieve a self-sustaining fully reprogrammed status,
in which the cells become independent of the activity of
the exogenous reprogramming factors and turn on the
expression of endogenous pluripotency regulators [64].
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Figure 2: linc-RoR as a paradigm for lncRNA regulation of pluripotency in the cytoplasm. In pluripotent cells, the levels of linc-RoR are
controlled by OCT4. In a positive feedback loop, linc-RoR sponges miR-145, thus derepressing its targets, including OCT4. OCT4 also
negatively controls miR-145 at the transcriptional level [41, 59–61]. See text for details.
lincRNA-p21
HNRPK
Pol II
H3K9me3
CpG methylation
Pre-iPSCs
lincRNA-p21
HNRPK
Pluripotency regulators (e.g.,
Nanog, Lin28, and Sox2) are off
iPSCs
HNRPK
(i) Endogenous pluripotency regulators are turned on
(ii) iPSCs achieve a self-sustaining self-renewal status
Oct4Nanog
Sox2
Sox2
Figure 3: lincRNA-p21 regulates the transition of pre-iPSCs to iPSCs. During reprogramming, the induction of endogenous pluripotency
genes is necessary to achieve a self-sustaining status in which the core regulatory factors act in a positive feedback loop on their own
expression. lincRNA-p21 hinders this transition by recruiting an inhibitory complex, which deposits repressive marks such as H3K9me3
and CpG methylation on the promoters of pluripotency regulators [62].
Three lncRNAs, including lincRNA-p21, had a negative effect
in pre-iPSCs to iPSCs conversion. Mechanistically, lincRNA-
p21 has been suggested to sustain the heterochromatic state at
pluripotency gene promoters by interacting with HNRNPK.
HNRNPK and lincRNA-p21 together would form a repressive
complex able to preserve H3K9me3 and CpG methylation at
the promoter of key pluripotency regulators such as Nanog,
Sox2, and Lin28 [62] (Figure 3). Besides lincRNA-p21, there
are only limited examples of nuclear lncRNAs regulating gene
expression by controlling DNAmethylation. In amore recent
paper, Wang and colleagues reported the identification of
Dum, a Developmental pluripotency-associated 2 (Dppa2)
Upstream binding Muscle lncRNA [65]. LncRNA Dum
was found to silence its neighboring gene Dppa2 in cis by
recruiting Dnmt1, Dnmt3a and Dnmt3b on its promoter.
Although the cited work was mainly focused on myogenic
differentiation, it is tempting to speculate that a similar
regulatory mechanism might play a role in pluripotent
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cells as well. Dppa2 is highly enriched in pluripotent cells
and activation of endogenous Dppa2 during late steps of
reprogramming specifically marks the small subset of cells
that will achieve full pluripotency, in which Dppa2-mediated
induction of Nanog transcription is a crucial event [66].
Therefore, it will be extremely interesting in the future to
assess whether the lncRNA Dum regulates critical steps of
reprogramming through modulation of Dppa2.
4. Concluding Remarks
Pluripotency is a unique property of ESCs and iPSCs, which
are the only cell types able to undergo indefinite self-renewal
and differentiation into derivatives of the three germ layers.
Pluripotent cells therefore represent both ideal candidates for
dissecting the mechanisms of early embryonic development
and potential therapeutic tools for regenerative medicine.
Patient-specific iPSCs also provide in vitro platforms to
model human disease and to test drugs in preclinical studies.
Such potential applications, however, are subordinated to a
deepunderstanding of themolecularmechanismsunderlying
pluripotency.
An orchestra of transcription factors, chromatin reg-
ulators, signaling transducers, miRNAs and lncRNAs play
coordinately in pluripotent cells. Each of them cannot be
considered a solo player. Complex networks and feed-
back loops exist, which comprise members of each class
of regulatory factors. A huge increase of transcriptome-
wide analyses, facilitated by recent advancements in next-
generation sequencing technologies, uncovered a universe
of long noncoding transcripts. While there is no general
consensus on the extent of the global impact of lncRNAs
on the regulation of cell identity and differentiation, few
examples in which selected lncRNAs have been more deeply
analyzed exist. As discussed in this review, at least a subset
of known lncRNAs are as important as previously defined
“core transcription factors” in the context of pluripotent cells
(Table 1). The paucity of functional studies is in striking
contrast with the number of annotated lncRNAs (thousands)
that are specifically enriched in ESCs and/or described as
interactors of crucial pluripotency regulators, such as Poly-
comb andTrithorax complexes.We expect, in the near future,
a substantial increase of functional studies describing new
examples of lncRNAs acting in network with other master
regulators in the definition of the pluripotent state.
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